Open mitochondrial research · Plain-language explainer

Published on Zenodo · August 29, 2026

Paired Tumor-Host Bioenergetic Phenotyping in Cancer: A Translational Research Framework Linking Mitochondrial Biology to Patient Function

Friedl, Andrew

Abstract

This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay.

DOI: 10.5281/zenodo.22164368

Read the full paperRead the public summary

The paper at a glance

The question

This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay.

Main takeaway

This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay.

Important caution

This is a research synthesis, not clinical guidance. The paper describes uncertainty and limits in the underlying evidence.

Why this matters

This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay.

How the research was done

This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay.

What the researchers found

This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay.

What this does not prove

This is a research synthesis, not clinical guidance. The paper describes uncertainty and limits in the underlying evidence.

What researchers should test next

This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay.

Helpful definitions

Key terms in plain English

MitochondriaStructures inside cells that convert fuel into energy the cell can use.

For non-specialists

What this could mean for patients and families

This research helps organize how scientists think about paired tumor-host bioenergetic phenotyping in cancer: a translational research framework linking mitochondrial biology to patient function. This manuscript proposes a paired tumor-host bioenergetic phenotyping framework connecting tumor mitochondrial phenotype, host functional phenotype, treatment exposure, and clinically important tumor and host outcomes. The framework is intended to motivate collaborative validation and actionable care pathways, not to claim that the Energy Score is itself a direct mitochondrial assay. It does not establish a diagnosis, prove that a treatment works, or tell an individual person what care to pursue.

  • What was directly measured, and what was inferred?
  • Were the findings in people, animals, cells, or a mixture?
  • What result would disprove or narrow the proposed explanation?
Track symptoms and function over time →Join Mito Map as a researcher →